Home
Scholarly Works
Rivaroxaban in treatment refractory...
Journal article

Rivaroxaban in treatment refractory heparin-induced thrombocytopenia

Abstract

Following orthopaedic surgery, a 56-year-old woman developed heparin-induced thrombocytopenia (HIT), complicated by extensive proximal deep vein thrombosis. The patient did not respond to multiple conventional therapies; however, a prompt treatment response occurred after starting rivaroxaban at standard dosing. This case represents the first documentation of efficacy for rivaroxaban in the setting of treatment refractory HIT and strengthens the limited existing evidence for this agent in HIT.

Authors

Casan JML; Grigoriadis G; Chan N; Chunilal S

Journal

BMJ Case Reports, Vol. 2016, ,

Publisher

BMJ

Publication Date

August 12, 2016

DOI

10.1136/bcr-2016-216110

ISSN

1757-790X

Contact the Experts team